PDB Short entry for 2PCO HEADER TOXIN 30-MAR-07 2PCO TITLE SPATIAL STRUCTURE AND MEMBRANE PERMEABILIZATION FOR LATARCIN-1, A TITLE 2 SPIDER ANTIMICROBIAL PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: LATARCIN-1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: LTC-1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THIS SEQUENCE SOURCE 4 OCCURS NATURALLY IN SPIDER (LACHESANA TARABAEVI) VENOM. KEYWDS CONTINUOUS HELIX, TOXIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR P.V.DUBOVSKII,P.E.VOLYNSKY,A.A.POLYANSKY,V.V.CHUPIN,R.G.EFREMOV, AUTHOR 2 A.S.ARSENIEV REVDAT 3 16-MAR-22 2PCO 1 REMARK REVDAT 2 24-FEB-09 2PCO 1 VERSN REVDAT 1 18-MAR-08 2PCO 0 JRNL AUTH P.V.DUBOVSKII,P.E.VOLYNSKY,A.A.POLYANSKY,D.V.KARPUNIN, JRNL AUTH 2 V.V.CHUPIN,R.G.EFREMOV,A.S.ARSENIEV JRNL TITL THREE-DIMENSIONAL STRUCTURE/HYDROPHOBICITY OF LATARCINS JRNL TITL 2 SPECIFIES THEIR MODE OF MEMBRANE ACTIVITY. JRNL REF BIOCHEMISTRY V. 47 3525 2008 JRNL REFN ISSN 0006-2960 JRNL PMID 18293934 JRNL DOI 10.1021/BI702203W REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 1.0.6., FANMEM 4.1 REMARK 3 AUTHORS : GUENTERT P. (CYANA), NOLDE, ARSENIEV, VERGOTEN, REMARK 3 EFREMOV (FANMEM) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IN TOTAL, 146 DISTANCE AND 127 TORSION REMARK 3 ANGLE CONSTRAINTS WERE USED REMARK 4 REMARK 4 2PCO COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-APR-07. REMARK 100 THE DEPOSITION ID IS D_1000042230. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 318 REMARK 210 PH : 7.1 REMARK 210 IONIC STRENGTH : SALT-FREE REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2 MM LTC1, 120 MM PERDEUTERATED REMARK 210 SDS, PH 7.1, SALT-FREE, 90% H2O, REMARK 210 10% D2O; 2 MM LTC1, 120 MM REMARK 210 PERDEUTERATED SDS, PH 7.1, SALT- REMARK 210 FREE, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D TOCSY; 2D NOESY; DQF-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 3.1.A, XEASY 40300000 REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 TRP A 7 -60.26 -154.84 REMARK 500 1 GLU A 25 -61.35 -162.62 REMARK 500 2 TRP A 7 -61.31 -147.23 REMARK 500 3 MET A 6 34.79 -160.16 REMARK 500 4 TRP A 7 -58.40 -150.94 REMARK 500 5 GLU A 25 70.66 57.52 REMARK 500 6 MET A 6 84.27 48.34 REMARK 500 6 GLU A 25 -61.18 -161.16 REMARK 500 7 TRP A 7 -58.17 -141.58 REMARK 500 7 GLU A 25 71.57 53.55 REMARK 500 9 TRP A 7 -63.48 -139.75 REMARK 500 10 MET A 6 -59.65 -156.33 REMARK 500 10 TRP A 7 -72.46 -163.65 REMARK 500 10 GLU A 25 75.07 54.37 REMARK 500 11 TRP A 3 64.97 61.02 REMARK 500 11 ARG A 8 -47.59 -145.52 REMARK 500 11 LYS A 13 -56.32 -144.33 REMARK 500 12 MET A 6 88.22 54.53 REMARK 500 14 TRP A 7 -58.34 -155.28 REMARK 500 15 TRP A 7 -56.50 -159.00 REMARK 500 15 GLU A 25 71.62 53.50 REMARK 500 16 MET A 2 72.58 53.06 REMARK 500 17 TRP A 7 -63.02 -145.84 REMARK 500 19 MET A 6 30.05 -149.39 REMARK 500 20 MET A 6 81.79 52.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2G9P RELATED DB: PDB REMARK 900 LTC2A, AN ANTIMICROBIAL PEPTIDE BELONGING ALSO TO THE LATARCIN REMARK 900 FAMILY DBREF 2PCO A 1 26 UNP Q1ELT9 LAT1_LACTA 63 88 SEQRES 1 A 26 SER MET TRP SER GLY MET TRP ARG ARG LYS LEU LYS LYS SEQRES 2 A 26 LEU ARG ASN ALA LEU LYS LYS LYS LEU LYS GLY GLU LYS HELIX 1 1 TRP A 7 GLY A 24 1 18 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000